AzTrials
AzTrials

Brain InjuryBDOD-TNNCT06948669

Brain Death and Organ Donation in Tunisian Intensive Care Units

An observational study of Brain Injury and Coma, run by Faculty of Medicine, Sousse at 1 site in Tunisia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study was to identify factors associated with the progression to brain death in critically ill patients with severe brain injuries in Tunisian intensive care units (ICUs). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Brain Injury, Coma, Organ Transplants
How many people
104 participants
Where
1 siteTunisia
Study dates
1 Nov 2022to 25 Nov 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This prospective observational study enrolled 104 adult patients (≥18 years) with severe coma (Glasgow Coma Scale ≤8) requiring mechanical ventilation across three intensive care units in Tunisia. Key Features: Age/Sex: Mean age 47 years (range 18-80), 76% male Primary Conditions: Traumatic brain injury (61%) Hemorrhagic stroke (19%) Other neurological causes (20%) Study Groups: 26 patients (25%) progressed to brain death 78 patients (75%) did not Justification: The population represents typical severe coma cases in North African ICUs, with standardized brain death confirmation per national protocols (clinical exam + CT angiography).

Who may be able to join

  • Adults ≥18 years admitted to ICU with:
  • Severe coma (Glasgow Coma Scale ≤8)
  • Requiring mechanical ventilation
  • Primary diagnosis of:
  • Traumatic brain injury (TBI)
  • Hemorrhagic stroke
Show all 9Show fewer
  • Other severe neurological conditions (anoxic brain injury, etc.)
  • Potential organ donor status (for brain death subgroup):
  • Meets clinical brain death criteria (absent brainstem reflexes, apnea)

Who cannot join

  • Non-neurological terminal conditions: e.g., Advanced cancer

Trial locations and contacts

1 site in 1 country.

Tunisia1 site
  • Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia

    Sousse, 4002

Other trials in Tunisia

About this study

Official title: Predictors of Brain Death and Barriers to Organ Donation in a North African Intensive Care Units: A Multicenter Prospective Study on Severe Coma Patients

The goal of this observational study was to identify factors associated with the progression to brain death in critically ill patients with severe brain injuries in Tunisian intensive care units (ICUs). The main questions it aimed to answer were:

What medical factors (e.g., type of brain injury, ICU stay duration) increased the likelihood of progressing to brain death in these patients?

Read more

What patient characteristics (e.g., age, comorbidities) influenced the risk of brain death?

What were the reasons behind low organ donation rates in Tunisia, including family refusal and hospital-level barriers?

Participants were:

Adults with severe coma (Glasgow Coma Scale ≤ 8) requiring mechanical ventilation in Tunisian ICUs.

Data were collected as part of routine medical care, including information about medical factors, patient characteristics, and family attitudes towards organ donation, without any additional interventions beyond standard care.

The study was conducted from November 2022 to November 2023 across three ICUs: Sahloul, Farhat Hached, and Mohamed Taher Maamouri Hospitals.

Read the detailed description

Background

Brain death (BD) is a legally and medically recognized condition under which organ donation may occur. However, organ donation rates in Tunisia remain low compared to international benchmarks. There is a need to better understand the factors influencing the progression to brain death in ICU patients, as well as the sociocultural and institutional barriers to organ donation in this setting.

Objectives

This study aimed to:

Identify clinical predictors of brain death among critically ill patients with severe brain injuries

Explore reasons for organ donation refusal by families

Identify hospital-level barriers in the organ donation process

Study Design and Setting

This was a prospective observational cohort study conducted between November 2022 and November 2023 in three Tunisian intensive care units:

Sahloul University Hospital (trauma center)

Farhat Hached University Hospital

Mohamed Taher Maamouri Hospital

Participants

Adult patients (≥18 years) admitted with severe coma (Glasgow Coma Scale ≤ 8) requiring mechanical ventilation were included. Patients with terminal illnesses unrelated to brain injury were excluded.

Procedures Data Collection

Data were prospectively collected using a standardized form developed and validated by experts in intensive care and the Tunisian National Centre for Organ Promotion and Transplantation (CNPTO).

The collected variables included:

Demographic information (e.g., age, sex)

Clinical characteristics (e.g., Glasgow Coma Scale on ICU admission, comorbidities, primary diagnosis)

Patient outcomes (e.g., progression to brain death, ICU discharge, or death from other causes)

Length of ICU stay

Organ donation process variables (e.g., whether families were approached, family consent or refusal, organ procurement, reasons for refusal)

Family approaches were conducted by the national transplant coordination team from the CNPTO.

No experimental interventions were applied. All procedures were part of standard ICU care.

Keywords
Organ donation refusal, ICU donor management, Cultural barriers, Hemorrhagic stroke outcome
Medical subject headings
Brain Injuries, Coma

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brain death incidence

    Proportion of patients progressing to brain death (clinical + CT angiography).

    Measured: 0-12 months

  2. Family donation refusal rate

    Percentage of families declining organ donation, with reasons

    Measured: At time of brain death confirmation (through study completion, an average of 1 year)

Secondary outcomes (1)
  1. Multivariate analysis of brain death predictors

    Adjusted odds ratios (OR) for: 1) hemorrhagic stroke, 2) traumatic brain injury, and 3) ICU stay >14 days as independent predictors of brain death progression

    Measured: From ICU admission to outcome determination (up to 1 year)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2025
  2. Study start1 Nov 2022
  3. Primary completion1 Nov 2023
  4. Study completion25 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06948669
Sponsor's protocol ID
BDOD-Tunisia-2022-2023
Other IDs
HS13-2022
Acronym
BDOD-TN
Status last verified
Apr 2025
First submitted
11 Apr 2025
Last updated
29 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No (but de-identified aggregate data will be published in the manuscript).

Publications

  • Slama I, Chouchene I, Ghammam R, Durin L, Naija W, Ziadi J, Ben Saad H. Predictors of brain death and barriers to organ donation in north African intensive care units: a multicenter prospective study on severe coma patients. Libyan J Med. 2025 Dec;20(1):2545049. doi: 10.1080/19932820.2025.2545049. Epub 2025 Aug 12.

    PubMed 40794438

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Injury and Coma, run by Faculty of Medicine, Sousse at 1 site in Tunisia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Tunisia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brain death incidence (time frame: 0-12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06948669, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in